Skip to content

Clinical trials

Completed Hypersensitivity trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Status: Completed Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20143
20151
20161
20172
20182
20214
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangzhou Institute of Respiratory Disease3
Colgate Palmolive2
Pierre Fabre Dermo Cosmetique2
Société des Produits Nestlé (SPN)2
Sun Yat-sen University2
Changhai Hospital1
Guangdong Provincial People's Hospital1
Jiangsu Kanion Pharmaceutical Co., Ltd1
Lin Chen1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity18
Asthma4
Dermatitis, Atopic3
Immune System Diseases2
Inflammation2
Rhinitis, Allergic2
Skin Diseases2
Bronchial Hyperreactivity1
Critical Illness1
Dentin Sensitivity1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.